ScholarLens Back to search
2018•Kölner Universitäts PublikationsServer (Universität zu Köln)Requires access

Extracorporeal Photopheresis (ECP) Therapy with UVADEX (R) (methoxsalen) Improved Quality of Life (QoL) for National Institutes of Health (NIH)-graded Moderate to Severe Chronic Graft-vs-Host Disease (cGvHD)

Madan Jagasia, Hildegard T. Greinix, Christoph Scheid, Gèrard Socié, Francis Ayuketang Ayuk, Johanna Tischer, Michèle L. Donato, Árpád Bátai, Heidi Chen, Sheau‐Chiann Chen, Thomas K. Chin, Henri Boodée, Ghaith Mitri

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Extracorporeal Photopheresis, Photopheresis, Medicine, Graft-versus-host disease, Quality of life (healthcare), Methoxsalen, Surgery, Disease

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Extracorporeal Photopheresis (ECP) Therapy with UVADEX (R) (methoxsalen) Improved Quality of Life (QoL) for National Institutes of Health (NIH)-graded Moderate to Severe Chronic Graft-vs-Host Disease (cGvHD) — Research Paper | ScholarLens